Analyst David Lewis works at MORGAN STANLEY and is focused on the Healthcare sector with 716 price targets and ratings documented since 2012 spanning on 23 stocks. Analyst's average stock valuation to be materialised ratio is 83.6% with an average time for price targets to be met of 232.64 days.
Most recent stock forecast was given on PODD, Insulet Corporation at 04-Nov-2022.
David Lewis best performing recommendations are on SWAV (SHOCKWAVE MEDICAL, INC).
The best stock recommendation documented was for NVRO (NEVRO CORP) at 11/6/2018. The price target of $43 was fulfilled within 2 days with a profit of $4.85 (12.71%) receiving and performance score of 63.56.
Average potential price target upside